USANA Health Sciences, Inc. (NYSE: USNA) yesterday announced financial results for its fiscal second quarter ended June 27, 2020.
According to the company, continued strong demand and successful promotions combined to generate $259.0 million in net sales, up 1.2 percent versus prior-year quarter. Active customers totaled 599,000, an increase of 7.9 percent versus the prior-year quarter.
“During the quarter, we generated nearly 8 percent growth in active customers, due to double-digit customer growth in three-of-our-four regions, including the Americas and Europe region,” said Kevin Guest, chief executive officer and chairman of the Board. “We also continued to successfully execute a virtual sales and operating strategy to deliver our results. This strategy included USANA hosting its first all-virtual Asia Pacific Convention, as well as the facilitation of other technology-based tools that assisted our Associates in their sales efforts. Finally, we offered several promotions and incentives during the quarter that benefitted net sales and our overall results.”
Q2 2020 Regional Results:
- Asia Pacific: $209.3 million, up 1.9% from prior-year quarter
- Greater China: $124.0 million, down 3.8% from prior-year quarter
- North Asia: $25.9 million, up 19.1% from prior-year quarter
- Southeast Asia Pacific: $59.5 million, up 10.2% from prior-year quarter
- America & Europe: $49.7 million, down 1.7% from prior-year quarter
The company is updating its consolidated net sales—from $1.00–$1.08 billion to $1.05–$1.10 billion—and earnings per share outlook—from $4.00–$4.90 to $4.70–$5.25—for fiscal year 2020.
“We are raising our full-year guidance to reflect a solid second quarter as well as our expectations for the back-half of the year,” said Guest. “We recognize that we cannot anticipate all of the challenges that might arise as a result of the ongoing COVID-19 pandemic, but we believe that we are positioned to continue adapting to an evolving operating environment.”
To read the complete USANA Q2 2020 report, click here.